Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Gut

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Overall survival ‐ FOLFIRINOX · advanced pancreatic cancer

Various types of chemotherapy probably leads to lower overall survival ‐ FOLFIRINOX compared with gemcitabine (moderate certainty).

1 finding from 1 review

Chemotherapy and radiotherapy for advanced pancreatic cancer 2018 · Cochrane Headline outcomes only
HR 0.51 [0.43, 0.6]
2 studies · 652 participants
Moderate